1. Home
  2. VNRX vs TSE Comparison

VNRX vs TSE Comparison

Compare VNRX & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • TSE
  • Stock Information
  • Founded
  • VNRX N/A
  • TSE 2010
  • Country
  • VNRX United States
  • TSE United States
  • Employees
  • VNRX N/A
  • TSE N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • TSE Major Chemicals
  • Sector
  • VNRX Health Care
  • TSE Industrials
  • Exchange
  • VNRX Nasdaq
  • TSE Nasdaq
  • Market Cap
  • VNRX 69.7M
  • TSE 68.0M
  • IPO Year
  • VNRX N/A
  • TSE 2014
  • Fundamental
  • Price
  • VNRX $0.39
  • TSE $1.23
  • Analyst Decision
  • VNRX Strong Buy
  • TSE
  • Analyst Count
  • VNRX 4
  • TSE 0
  • Target Price
  • VNRX $3.50
  • TSE N/A
  • AVG Volume (30 Days)
  • VNRX 1.1M
  • TSE 447.1K
  • Earning Date
  • VNRX 11-14-2025
  • TSE 11-06-2025
  • Dividend Yield
  • VNRX N/A
  • TSE 3.25%
  • EPS Growth
  • VNRX N/A
  • TSE N/A
  • EPS
  • VNRX N/A
  • TSE N/A
  • Revenue
  • VNRX $1,319,252.00
  • TSE $3,133,800,000.00
  • Revenue This Year
  • VNRX $324.32
  • TSE N/A
  • Revenue Next Year
  • VNRX $247.82
  • TSE $5.20
  • P/E Ratio
  • VNRX N/A
  • TSE N/A
  • Revenue Growth
  • VNRX 35.10
  • TSE N/A
  • 52 Week Low
  • VNRX $0.39
  • TSE $1.15
  • 52 Week High
  • VNRX $0.94
  • TSE $6.85
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 29.55
  • TSE 28.41
  • Support Level
  • VNRX $0.42
  • TSE $1.32
  • Resistance Level
  • VNRX $0.48
  • TSE $1.49
  • Average True Range (ATR)
  • VNRX 0.04
  • TSE 0.16
  • MACD
  • VNRX 0.00
  • TSE -0.01
  • Stochastic Oscillator
  • VNRX 2.22
  • TSE 13.51

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: